查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945267

2026年全球心臟病診斷市場報告

Heart Attack Diagnostic Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，心臟病診斷市場顯著擴張，預計將從2025年的115.4億美元成長到2026年的126.4億美元，複合年成長率為9.5%。過去幾年的成長可歸因於心血管疾病盛行率的上升、醫院診斷能力的增強、心臟影像技術的普及、人們對早期心肌梗塞檢測意識提升以及檢測方法的進步。

預計未來幾年，心臟病診斷市場規模將強勁成長，到2030年將達到179億美元，複合年成長率（CAGR）為9.1%。預測期內的成長要素包括：對快速診斷解決方案的需求不斷成長、數位健康平台的日益融合、遠端心臟監測的廣泛應用、對先進成像技術投資的增加以及精準心臟病診斷的日益普及。預測期內的主要趨勢包括：人工智慧輔助診斷工具的日益普及、高靈敏度心臟生物標記的使用日益增多、就地檢驗設備的日益融合、非侵入性診斷程序的擴展以及對快速緊急診斷的日益重視。

心臟病患病率的不斷上升正在推動心臟病診斷市場的成長。心血管疾病（CVD）涵蓋多種影響心臟和血管的疾病。導致心臟病和中風的主要因素包括不健康的飲食、缺乏運動、吸煙和酗酒。心臟病診斷對於評估心臟病、中風和心臟衰竭的原因和嚴重程度至關重要。例如，根據英國政府機構－健康改善與差異辦公室（Office for Health Improvement and Disparities）於2024年3月發布的數據，2023年英格蘭有超過186.25萬人（佔總人口的3%）被全科醫生（GP）診斷出患有心臟疾病（CHD）。這一數字表明，自2010年底以來，冠心病的診斷率有所下降。因此，心血管疾病發生率的上升預計將繼續推動心臟病診斷市場的發展。

心臟病診斷市場的主要企業始終走在創新前沿，並不斷推出突破性產品，例如冠狀動脈疾病檢測。這些檢測旨在識別冠狀動脈疾病，其特徵是冠狀動脈狹窄或阻塞。例如，2023年8月，Cardio Diagnostics Holdings Inc.推出了「PrecisionCHD」檢測。這項心臟疾病（CHD）血液檢測獨特地將表觀遺傳和遺傳生物標記與人工智慧（AI）相結合。值得注意的是，PrecisionCHD檢測為傳統的冠心病檢測工具提供了一種快速高效的替代方案，其便捷之處在於只需採集簡單的血液樣本，即可在10個工作天內獲得快速結果。這項創新體現了主要企業致力於滿足不斷變化的客戶需求、推動銷售並增加心臟病診斷市場收入的承諾。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球心臟病診斷市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 人工智慧（AI）和自主人工智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 生物技術、基因組學和精準醫學
    • 物聯網、智慧基礎設施和互聯生態系統
    • 工業4.0和智慧製造
  • 主要趨勢
    • 人工智慧輔助診斷工具的廣泛應用
    • 敏感心臟生物標記的應用日益廣泛
    • 就地檢驗設備的整合應用正在興起
    • 擴大非侵入性診斷程序
    • 越來越重視快速急診診斷

第5章 終端用戶產業市場分析

  • 醫院
  • 門診手術中心
  • 診斷中心
  • 心臟護理診所
  • 急診中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球心臟病診斷市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球心臟病診斷市場規模、對比及成長率分析
  • 全球心臟病診斷市場表現：規模與成長，2020-2025年
  • 全球心臟病診斷市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按測試類型
  • 心電圖（ECG 或 EKG）、血液檢查、心臟超音波圖、冠動脈攝影術（血管攝影）
  • 按程式
  • 侵入性和非侵入性手術
  • 按最終用途行業分類
  • 醫院、門診手術中心、診斷中心和其他最終用戶
  • 按類型細分：心電圖（ECG 或 EKG）
  • 靜態心電圖、動態心電圖、心臟事件記錄器
  • 按類型細分：血液檢測
  • 心臟生物標記、血脂譜、B型鈉尿肽（BNP）
  • 按類型細分：心臟超音波圖
  • 胸前心臟超音波（TTE）、經食道心臟心臟超音波圖（TEE）、心臟超音波圖
  • 按類型細分：冠動脈攝影術造影
  • 冠動脈攝影術、右心導管檢查、左心導管檢查術

第10章 區域與國家分析

  • 全球心臟病診斷市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球心臟病診斷市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 心臟病診斷市場：競爭格局與市場佔有率，2024 年
  • 心臟病診斷市場：公司估值矩陣
  • 心臟病診斷市場：公司概況
    • Abbott Laboratories
    • F. Hoffmann-La Roche AG
    • General Electric Co.
    • Koninklijke Philips NV
    • Siemens AG

第37章：其他領先和創新企業

  • Canon Medical Systems Corporation, GE Healthcare, Roche Diagnostics, Beckman Coulter Inc., Schiller AG, Becton Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics, Bio-Rad Laboratories Inc., Hitachi Ltd., Toshiba Corp., Fujifilm Holdings, Midmark Corp., Welch Allyn Inc.

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年心臟病診斷市場：提供新機會的國家
  • 2030年心臟病診斷市場：新興細分市場機會
  • 2030年心臟病診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MHADT01_G26Q1

Heart attack diagnostics encompass methods for identifying, monitoring, screening, and prognosticating to validate the diagnosis of a heart attack. These diagnostics aid in determining the type of heart attack a patient has experienced, facilitating the selection of the most effective treatment. They play a crucial role in diagnosing heart disease.

The primary types of heart attack diagnostic tests include electrocardiogram (ECG/EKG), blood tests, X-ray, echocardiogram, coronary catheterization (angiogram), exercise stress test, and magnetic resonance imaging (MRI). These tests can be conducted through both invasive and non-invasive procedures. An electrocardiogram (ECG) is a rapid test that assesses the heart's electrical activity and rhythm by detecting signals produced during each heartbeat. It is valuable for diagnosing and monitoring heart-related conditions. These heart attack diagnostics are employed in various healthcare settings, including hospitals, ambulatory surgical centers, diagnostic centers, and other end-users.

Tariffs are influencing the heart attack diagnostic market by increasing costs of imported imaging equipment, diagnostic reagents, electronic sensors, and advanced monitoring systems. Hospitals and diagnostic centers in North America and Europe are most affected due to dependence on imported medical devices, while Asia-Pacific faces higher costs for advanced imaging equipment procurement. These tariffs are raising capital expenditure and delaying technology upgrades. However, they are also encouraging domestic manufacturing, local reagent production, and regional innovation in cost-efficient diagnostic solutions.

The heart attack diagnostic market research report is one of a series of new reports from The Business Research Company that provides heart attack diagnostic market statistics, including heart attack diagnostic industry global market size, regional shares, competitors with a heart attack diagnostic market share, detailed heart attack diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the heart attack diagnostic industry. This heart attack diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The heart attack diagnostic market size has grown strongly in recent years. It will grow from $11.54 billion in 2025 to $12.64 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, expansion of hospital diagnostic capabilities, improved availability of cardiac imaging technologies, increasing awareness of early heart attack detection, advancements in laboratory testing methods.

The heart attack diagnostic market size is expected to see strong growth in the next few years. It will grow to $17.9 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostic solutions, growing integration of digital health platforms, expansion of remote cardiac monitoring, rising investments in advanced imaging technologies, increasing adoption of precision cardiology diagnostics. Major trends in the forecast period include increasing adoption of ai-assisted diagnostic tools, rising use of high-sensitivity cardiac biomarkers, growing integration of point-of-care testing devices, expansion of non-invasive diagnostic procedures, enhanced focus on rapid emergency diagnostics.

The increasing prevalence of cardiac disorders is driving the growth of the heart attack diagnostics market. Cardiovascular diseases (CVD) encompass a range of conditions affecting the heart and blood vessels. Key contributors to heart disease and stroke include unhealthy diets, physical inactivity, tobacco use, and alcohol abuse. Diagnosing heart attacks is crucial for assessing the causes and severity of heart attacks, strokes, and heart failure. For example, in March 2024, data from the Office for Health Improvement and Disparities, a UK government entity, revealed that in 2023, over 1,862,500 individuals (3%) in England had received a GP diagnosis of coronary heart disease (CHD). This figure represents a decrease in the percentage of people diagnosed with CHD since the fiscal year ending in 2010. Consequently, the rising incidence of cardiovascular diseases is expected to continue fueling the heart attack diagnostics market.

Major companies in the heart attack diagnostics market are at the forefront of innovation, introducing groundbreaking products such as coronary heart disease detection tests. These tests are designed to identify the presence of coronary heart disease, characterized by the narrowing or blockage of coronary arteries. For instance, in August 2023, A notable product in this category is the PrecisionCHD test launched by Cardio Diagnostics Holdings Inc. This blood-based detection method for Coronary Heart Disease (CHD) uniquely integrates epigenetic and genetic biomarkers with Artificial Intelligence (AI). Notably, the PrecisionCHD test provides a rapid and efficient alternative to traditional CHD detection tools, offering convenience with a straightforward blood sample and swift results within 10 business days. This innovation reflects the commitment of major companies to meet evolving customer needs, drive sales, and elevate revenue in the heart attack diagnostics market.

In August 2024, Johnson & Johnson, a US-based pharmaceutical company, acquired V-Wave Inc. for an undisclosed sum. This acquisition is part of Johnson & Johnson's strategy to enhance its portfolio, foster innovation, and broaden its market presence in the healthcare sector. V-Wave Inc., based in California, specializes in creating advanced medical devices and therapies aimed at managing heart failure.

Major companies operating in the heart attack diagnostic market are Abbott Laboratories, F. Hoffmann-La Roche AG, General Electric Co., Koninklijke Philips NV, Siemens AG, Canon Medical Systems Corporation, GE Healthcare, Roche Diagnostics, Beckman Coulter Inc., Schiller AG, Becton Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics, Bio-Rad Laboratories Inc., Hitachi Ltd., Toshiba Corp., Fujifilm Holdings, Midmark Corp., Welch Allyn Inc., HILL ROM HOLDINGS Inc., HeartFlow, Cardio Diagnostics Holdings Inc.

North America was the largest region in the heart attack diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart attack diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the heart attack diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The heart attack diagnostics market includes revenues earned by entities through tests such as stress tests, cardiac catheterization, cardiac computerized tomography (CT) scan, cardiac magnetic resonance imaging (MRI), and angiogram. The market value includes the value of related goods sold by the service provider or included within the service offering. The heart attack diagnostics market also includes sales of wearable ECG devices, cardiac pacemakers, stents, and ventricular assist devices (VADs) which are used in heart attack diagnostics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Heart Attack Diagnostic Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses heart attack diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for heart attack diagnostic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The heart attack diagnostic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Test Type: Electrocardiogram (ECG Or EKG); Blood Tests; Echocardiogram; Coronary Catheterization (Angiogram)
  • 2) By Procedure: Invasive Procedure; Non-Invasive Procedure
  • 3) By End-Use Industry: Hospitals; Ambulatory Surgical Centers; Diagnostics Centers; Other End-Users
  • Subsegments:
  • 1) By Electrocardiogram (ECG Or EKG): Resting ECG; Holter Monitor; Event Monitor
  • 2) By Blood Tests: Cardiac Biomarkers; Lipid Panel; B-Type Natriuretic Peptide (BNP)
  • 3) By Echocardiogram: Transthoracic Echocardiogram (TTE); Transesophageal Echocardiogram (TEE); Doppler Echocardiogram
  • 4) By Coronary Catheterization (Angiogram): Coronary Angiography; Right Heart Catheterization; Left Heart Catheterization
  • Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche AG; General Electric Co.; Koninklijke Philips NV; Siemens AG; Canon Medical Systems Corporation; GE Healthcare; Roche Diagnostics; Beckman Coulter Inc.; Schiller AG; Becton Dickinson and Company; Danaher Corporation; Thermo Fisher Scientific Inc.; Quest Diagnostics; Bio-Rad Laboratories Inc.; Hitachi Ltd.; Toshiba Corp.; Fujifilm Holdings; Midmark Corp.; Welch Allyn Inc.; HILL ROM HOLDINGS Inc.; HeartFlow; Cardio Diagnostics Holdings Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Heart Attack Diagnostic Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Heart Attack Diagnostic Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Heart Attack Diagnostic Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Heart Attack Diagnostic Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Biotechnology, Genomics & Precision Medicine
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Ai-Assisted Diagnostic Tools
    • 4.2.2 Rising Use Of High-Sensitivity Cardiac Biomarkers
    • 4.2.3 Growing Integration Of Point-Of-Care Testing Devices
    • 4.2.4 Expansion Of Non-Invasive Diagnostic Procedures
    • 4.2.5 Enhanced Focus On Rapid Emergency Diagnostics

5. Heart Attack Diagnostic Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centers
  • 5.3 Diagnostic Centers
  • 5.4 Cardiac Care Clinics
  • 5.5 Emergency Medical Centers

6. Heart Attack Diagnostic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Heart Attack Diagnostic Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Heart Attack Diagnostic PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Heart Attack Diagnostic Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Heart Attack Diagnostic Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Heart Attack Diagnostic Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Heart Attack Diagnostic Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Heart Attack Diagnostic Market Segmentation

  • 9.1. Global Heart Attack Diagnostic Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Electrocardiogram (ECG Or EKG), Blood Tests, Echocardiogram, Coronary Catheterization (Angiogram)
  • 9.2. Global Heart Attack Diagnostic Market, Segmentation By Procedure, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Invasive Procedure, Non-Invasive Procedure
  • 9.3. Global Heart Attack Diagnostic Market, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Ambulatory Surgical Centers, Diagnostics Centers, Other End-Users
  • 9.4. Global Heart Attack Diagnostic Market, Sub-Segmentation Of Electrocardiogram (ECG Or EKG), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Resting ECG, Holter Monitor, Event Monitor
  • 9.5. Global Heart Attack Diagnostic Market, Sub-Segmentation Of Blood Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cardiac Biomarkers, Lipid Panel, B-Type Natriuretic Peptide (BNP)
  • 9.6. Global Heart Attack Diagnostic Market, Sub-Segmentation Of Echocardiogram, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Transthoracic Echocardiogram (TTE), Transesophageal Echocardiogram (TEE), Doppler Echocardiogram
  • 9.7. Global Heart Attack Diagnostic Market, Sub-Segmentation Of Coronary Catheterization (Angiogram), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Coronary Angiography, Right Heart Catheterization, Left Heart Catheterization

10. Heart Attack Diagnostic Market Regional And Country Analysis

  • 10.1. Global Heart Attack Diagnostic Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Heart Attack Diagnostic Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Heart Attack Diagnostic Market

  • 11.1. Asia-Pacific Heart Attack Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Heart Attack Diagnostic Market

  • 12.1. China Heart Attack Diagnostic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Heart Attack Diagnostic Market

  • 13.1. India Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Heart Attack Diagnostic Market

  • 14.1. Japan Heart Attack Diagnostic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Heart Attack Diagnostic Market

  • 15.1. Australia Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Heart Attack Diagnostic Market

  • 16.1. Indonesia Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Heart Attack Diagnostic Market

  • 17.1. South Korea Heart Attack Diagnostic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Heart Attack Diagnostic Market

  • 18.1. Taiwan Heart Attack Diagnostic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Heart Attack Diagnostic Market

  • 19.1. South East Asia Heart Attack Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Heart Attack Diagnostic Market

  • 20.1. Western Europe Heart Attack Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Heart Attack Diagnostic Market

  • 21.1. UK Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Heart Attack Diagnostic Market

  • 22.1. Germany Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Heart Attack Diagnostic Market

  • 23.1. France Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Heart Attack Diagnostic Market

  • 24.1. Italy Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Heart Attack Diagnostic Market

  • 25.1. Spain Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Heart Attack Diagnostic Market

  • 26.1. Eastern Europe Heart Attack Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Heart Attack Diagnostic Market

  • 27.1. Russia Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Heart Attack Diagnostic Market

  • 28.1. North America Heart Attack Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Heart Attack Diagnostic Market

  • 29.1. USA Heart Attack Diagnostic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Heart Attack Diagnostic Market

  • 30.1. Canada Heart Attack Diagnostic Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Heart Attack Diagnostic Market

  • 31.1. South America Heart Attack Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Heart Attack Diagnostic Market

  • 32.1. Brazil Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Heart Attack Diagnostic Market

  • 33.1. Middle East Heart Attack Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Heart Attack Diagnostic Market

  • 34.1. Africa Heart Attack Diagnostic Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Heart Attack Diagnostic Market, Segmentation By Test Type, Segmentation By Procedure, Segmentation By End-Use Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Heart Attack Diagnostic Market Regulatory and Investment Landscape

36. Heart Attack Diagnostic Market Competitive Landscape And Company Profiles

  • 36.1. Heart Attack Diagnostic Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Heart Attack Diagnostic Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Heart Attack Diagnostic Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. General Electric Co. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Siemens AG Overview, Products and Services, Strategy and Financial Analysis

37. Heart Attack Diagnostic Market Other Major And Innovative Companies

  • Canon Medical Systems Corporation, GE Healthcare, Roche Diagnostics, Beckman Coulter Inc., Schiller AG, Becton Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics, Bio-Rad Laboratories Inc., Hitachi Ltd., Toshiba Corp., Fujifilm Holdings, Midmark Corp., Welch Allyn Inc.

38. Global Heart Attack Diagnostic Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Heart Attack Diagnostic Market

40. Heart Attack Diagnostic Market High Potential Countries, Segments and Strategies

  • 40.1 Heart Attack Diagnostic Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Heart Attack Diagnostic Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Heart Attack Diagnostic Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer